Clinical Trial Results:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO AND ACTIVE COMPARATOR-CONTROLLED,
PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF RIVOGLITAZONE AS
MONOTHERAPY TREATMENT OF TYPE 2 DIABETES MELLITUS
Summary
|
|
EudraCT number |
2007-005263-97 |
Trial protocol |
HU LT DK |
Global completion date |
02 May 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 May 2016
|
First version publication date |
25 May 2016
|
Other versions |
|
Summary report(s) |
Report Synopsis CS0011-A-U302 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.